Peptide Therapeutics Forum 2026 (Basel, Switzerland)

The Peptide Therapeutics Forum is a leading interdisciplinary conference on bioactive peptides, bringing together academic and industrial groups to present state-of-the-art research from fundamental peptide science to pre-clinical and clinical drug candidates.

Thomas Fessard, PhD – Chief Executive Officer, will present on June 4 at 2:00 PM: “From Peptides to Drugs: Expanding the Frontiers of Medicinal Chemistry”

6th ACS MEDI Webinar

This webinar will focus on aspects of conformational control in drug design and will bring together participants interested in current approaches in medicinal chemistry and molecular design.

Gerhard Müller, PhD – Chief Scientific Officer, will lead a virtual webinar on June 17 at 1:30 PM ET: “Peptidomimetics: control and design of macrocycle backbone conformation”

EFMC-ACSMEDI Medicinal Chemistry Frontiers 2026 (Dublin, Ireland)

This joint symposium on medicinal chemistry will bring together scientists from academia and industry to discuss current advances in medicinal chemistry, drug discovery and molecular sciences.

Gerhard Müller, PhD – Chief Scientific Officer

Cédric Fries – Business Development Manager

Quentin Lefebvre, PhD – R&D Leader, will present on June 23 at 3:00 PM: “Aliphatic C-H Functionalization to Rapidly Access Non-Canonical Amino Acid Building Blocks”

BIO International 2026 (San Diego, United States)

BIO International is a major global biotechnology event, bringing together companies, investors and industry leaders across a broad life sciences landscape, with a strong focus on innovation, partnering and business development.

Thomas Fessard, PhD – Chief Executive Officer